Contribution of ligand structure to activation of alpha 2-adrenergic receptor subtype coupling to Gs

MG Eason, MT Jacinto and SB Liggett

Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710.

Recently, we have demonstrated that alpha 2-adrenergic receptors (alpha 2AR) functionally couple not only to Gi but also to Gs. This alpha 2AR- Gs coupling was subtype selective, in that the degree of alpha 2AR-Gs (but not -Gi) coupling was different between alpha 2AR subtypes. It is not known whether the determinants of this subtype selectively are found within the ligand-binding region of the receptor or within the intracellular G protein-coupling domains of the individual subtypes. We therefore expressed the three cloned human alpha 2AR (alpha 2C10, alpha 2C4, and alpha 2C2) in Chinese hamster ovary cells and studied the contribution of the ligand-binding domain to functional Gi versus Gs coupling, by determining the ability of various agonists (catecholamines, imidazolines, and azepines) to elicit alpha 2AR- mediated inhibition and stimulation of adenylyl cyclase activity. Isolation of Gi and Gs responses was accomplished by incubating cells with cholera or pertussis toxin, respectively. Although each compound was found to be a full agonist for alpha 2AR-Gi coupling, the efficacy of these agonists to elicit alpha 2AR-Gs coupling was markedly different, not only among drugs but also among the three alpha 2AR subtypes. The most notable differences occurred with the imidazoline agonists. Specifically, oxymetazoline stimulated adenylyl cyclase activity 210 +/- 17% for alpha 2C2 and 22 +/- 2.6% for alpha 2C10 and displayed no stimulation for alpha 2C4. UK-14304 stimulated adenylyl cyclase activity 240 +/- 16% for alpha 2C10, 160 +/- 14% for alpha 2C4, and 86 +/- 9% for alpha 2C2. Overall, the rank order of efficacy of these agonists to elicit stimulation of adenylyl cyclase activity by alpha 2C10 was epinephrine = norepinephrine = UK-14304 > BHT-933 > BHT- 920 > oxymetazoline. For alpha 2C4 the rank was epinephrine = norepinephrine = UK-14304, with oxymetazoline, BHT-920, and BHT-933 not eliciting any stimulation. For alpha 2C2 the rank was epinephrine = norepinephrine > oxymetazoline > UK-14304 = BHT-920 > BHT-933. Thus, the coupling of alpha 2AR subtypes to Gs occurs with endogenous catecholamines as well as multiple synthetic agonists, and the degree of Gs coupling is highly dependent on the structure of the agonist. Also, compounds that act as full agonists for Gi coupling are not necessarily full agonists for Gs coupling.

Volume 45, Issue 4, pp. 696-702, 04/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. M. Small, K. M. Brown, C. A. Seman, C. T. Theiss, and S. B. Liggett Complex haplotypes derived from noncoding polymorphisms of the intronless {alpha}2A-adrenergic gene diversify receptor expression PNAS, April 4, 2006; 103(14): 5472 - 5477. [Abstract] [Full Text] [PDF]

				D. W. McGraw and S. B. Liggett Molecular Mechanisms of {beta}2-Adrenergic Receptor Function and Regulation Proceedings of the ATS, November 1, 2005; 2(4): 292 - 296. [Abstract] [Full Text] [PDF]

				J. F. Heubach, U. Ravens, and A. J. Kaumann Epinephrine Activates Both Gs and Gi Pathways, but Norepinephrine Activates Only the Gs Pathway through Human {beta}2-Adrenoceptors Overexpressed in Mouse Heart Mol. Pharmacol., May 1, 2004; 65(5): 1313 - 1322. [Abstract] [Full Text]

				P. J. Pauwels, I. Rauly, and T. Wurch Dissimilar Pharmacological Responses by a New Series of Imidazoline Derivatives at Precoupled and Ligand-Activated {alpha}2A-Adrenoceptor States: Evidence for Effector Pathway-Dependent Differential Antagonism J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1015 - 1023. [Abstract] [Full Text] [PDF]

				T. Wurch, J. Okuda, and P. J. Pauwels Reciprocal Modulation of alpha 2A-Adrenoceptor and Galpha o Protein States as Determined by Carboxy-Terminal Mutagenesis of a Galpha o Protein Mol. Pharmacol., October 1, 2001; 60(4): 666 - 673. [Abstract] [Full Text] [PDF]

				I. Limon-Boulez, R. Bouet-Alard, T. W. Gettys, S. M. Lanier, J.-P. Maltier, and C. Legrand Partial Agonist Clonidine Mediates {alpha}2-AR Subtypes Specific Regulation of cAMP Accumulation in Adenylyl Cyclase II Transfected DDT1-MF2 Cells Mol. Pharmacol., February 1, 2001; 59(2): 331 - 338. [Abstract] [Full Text]

				K. Wenzel-Seifert and R. Seifert Molecular Analysis of beta 2-Adrenoceptor Coupling to Gs-, Gi-, and Gq-Proteins Mol. Pharmacol., November 1, 2000; 58(5): 954 - 966. [Abstract] [Full Text]

				C. B. Brink, S. M. Wade, and R. R. Neubig Agonist-Directed Trafficking of Porcine alpha 2A-Adrenergic Receptor Signaling in Chinese Hamster Ovary Cells: l-Isoproterenol Selectively Activates Gs J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 539 - 547. [Abstract] [Full Text]

				W.-N. Tian, D. D. Miller, and R. C. Deth Bidirectional Allosteric Effects of Agonists and GTP at alpha 2A/D-Adrenoceptors J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 664 - 671. [Abstract] [Full Text]

				Y.-Y. Zhou, H. Cheng, L.-S. Song, D. Wang, E. G. Lakatta, and R.-P. Xiao Spontaneous beta 2-Adrenergic Signaling Fails To Modulate L-Type Ca2+ Current in Mouse Ventricular Myocytes Mol. Pharmacol., September 1, 1999; 56(3): 485 - 493. [Abstract] [Full Text]

				W. Zhang, V. Klimek, J. T. Farley, M.-Y. Zhu, and G. A. Ordway alpha 2C Adrenoceptors Inhibit Adenylyl Cyclase in Mouse Striatum: Potential Activation by Dopamine J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1286 - 1292. [Abstract] [Full Text]

				D. W. Bonhaus, L. K. Chang, J. Kwan, and G. R. Martin Dual Activation and Inhibition of Adenylyl Cyclase by Cannabinoid Receptor Agonists: Evidence for Agonist-Specific Trafficking of Intracellular Responses J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 884 - 888. [Abstract] [Full Text]

				J. P. Kukkonen, A. Renvaktar, R. Shariatmadari, and K. E. O. Åkerman Ligand- and Subtype-Selective Coupling of Human Alpha-2 Adrenoceptors to Ca++ elevation in Chinese Hamster Ovary Cells J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 667 - 671. [Abstract] [Full Text]

				B. L. Wiens, C. S. Nelson, and K. A. Neve Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2S Dopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations Mol. Pharmacol., August 1, 1998; 54(2): 435 - 444. [Abstract] [Full Text]

				M.-L. Parmentier, C. Joly, S. Restituito, J. Bockaert, Y. Grau, and J.-P. Pin The G Protein-Coupling Profile of Metabotropic Glutamate Receptors, as Determined with Exogenous G Proteins, Is Independent of Their Ligand Recognition Domain Mol. Pharmacol., April 1, 1998; 53(4): 778 - 786. [Abstract] [Full Text]

				E. Thorin, S. M. Shreeve, N. Thorin-Trescases, and J. A. Bevan Reversal of Endothelin-1 Release by Stimulation of Endothelial {alpha}2-Adrenoceptor Contributes to Cerebral Vasorelaxation Hypertension, October 1, 1997; 30(4): 830 - 836. [Abstract] [Full Text]

				V. Reale, F. Hannan, L. M. Hall, and P. D. Evans Agonist-Specific Coupling of a Cloned Drosophila melanogaster D1-Like Dopamine Receptor to Multiple Second Messenger Pathways by Synthetic Agonists J. Neurosci., September 1, 1997; 17(17): 6545 - 6553. [Abstract] [Full Text] [PDF]

				A. Jinsi-Parimoo and R. C. Deth Reconstitution of alpha 2D-Adrenergic Receptor Coupling to Phospholipase D in a PC12 Cell Lysate J. Biol. Chem., June 6, 1997; 272(23): 14556 - 14561. [Abstract] [Full Text] [PDF]

				D. A. Daunt, C. Hurt, L. Hein, J. Kallio, F. Feng, and B. K. Kobilka Subtype-Specific Intracellular Trafficking of alpha 2-Adrenergic Receptors Mol. Pharmacol., May 1, 1997; 51(5): 711 - 720. [Abstract] [Full Text]

				J. Nasman, C. C. Jansson, and K. E.O. Akerman The Second Intracellular Loop of the alpha 2-Adrenergic Receptors Determines Subtype-specific Coupling to cAMP Production J. Biol. Chem., April 11, 1997; 272(15): 9703 - 9708. [Abstract] [Full Text] [PDF]

				E. A. Jewell-Motz and S. B. Liggett G Protein-coupled Receptor Kinase Specificity for Phosphorylation and Desensitization of alpha 2-Adrenergic Receptor Subtypes J. Biol. Chem., July 26, 1996; 271(30): 18082 - 18087. [Abstract] [Full Text] [PDF]

				M. G. Eason and S. B. Liggett Chimeric Mutagenesis of Putative G-protein Coupling Domains of the alpha 2A-Adrenergic Receptor. LOCALIZATION OF TWO REDUNDANT AND FULLY COMPETENT G J. Biol. Chem., May 31, 1996; 271(22): 12826 - 12832. [Abstract] [Full Text] [PDF]

				K. Nemeth and A. Chollet A Single Mutation of the Neurokinin-2 (NK2) Receptor Prevents Agonist-induced Desensitization J. Biol. Chem., November 17, 1995; 270(46): 27601 - 27605. [Abstract] [Full Text] [PDF]

				M. G. Eason and S. B. Liggett Identification of a G(s) Coupling Domain in the Amino Terminus of the Third Intracellular Loop of the alpha[IMAGE]-Adrenergic Receptor J. Biol. Chem., October 20, 1995; 270(42): 24753 - 24760. [Abstract] [Full Text] [PDF]

				T. M. Palmer, T. W. Gettys, and G. L. Stiles Differential Interaction with and Regulation of Multiple G-proteins by the Rat A[IMAGE] Adenosine Receptor J. Biol. Chem., July 14, 1995; 270(28): 16895 - 16902. [Abstract] [Full Text] [PDF]

				M. G. Eason, S. P. Moreira, and S. B. Liggett Four Consecutive Serines in the Third Intracellular Loop Are the Sites for beta-Adrenergic Receptor Kinase-mediated Phosphorylation and Desensitization of the alpha[IMAGE]-Adrenergic Receptor J. Biol. Chem., March 3, 1995; 270(9): 4681 - 4688. [Abstract] [Full Text] [PDF]

				E. A. Jewell-Motz, K. M. Small, C. T. Theiss, and S. B. Liggett alpha 2A/alpha 2C-Adrenergic Receptor Third Loop Chimera Show That Agonist Interaction with Receptor Subtype Backbone Establishes G Protein-coupled Receptor Kinase Phosphorylation J. Biol. Chem., September 8, 2000; 275(37): 28989 - 28993. [Abstract] [Full Text] [PDF]

				K. M. Small, K. M. Brown, S. L. Forbes, and S. B. Liggett Polymorphic Deletion of Three Intracellular Acidic Residues of the alpha 2B-Adrenergic Receptor Decreases G Protein-coupled Receptor Kinase-mediated Phosphorylation and Desensitization J. Biol. Chem., February 9, 2001; 276(7): 4917 - 4922. [Abstract] [Full Text] [PDF]